Home HKUMed identifies PLK4 as a promising therapeutic target for TP53 mutated AML, demonstrated in Queen Mary Hospital and other studies bymarketing@dongthinh.co.uk —January 07, 2024 0 HKUMed identifies PLK4 as a promising therapeutic target for TP53 mutated AML, demonstrated in Queen Mary Hospital and other studies * This article was originally published here
Post a Comment